- Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has raised GBP516,000 through a placing of 12,900,000 new ordinary shares at 4p per share.

The proceeds will be applied to working capital and to accelerate the US roll-out.

It has also issued 1,566,150 new ordinary shares to certain advisers in settlement of fees for services supplied to the company, at the placing price.

Story provided by